Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults

Korea University1 site in 1 country1,800 target enrollmentFebruary 2012

ConditionsMetabolic Syndrome, Atherosclerosis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Metabolic Syndrome, Atherosclerosis
Sponsor: Korea University
Enrollment: 1800
Locations: 1
Primary Endpoint: The impact of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) for developing metabolic syndrome in prospective design
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

In Asia, the prevalence of metabolic syndrome have been dramatically increased. Therefore, the investigators intend to the collect the blood sample, laboratory, anthropometric, and body composition parameters prospectively to examine the risk factors of metabolic syndrome. Furthermore, the investigators will collect the data of carotid IMT and branchial ankle pulse wave velocity to clarify the metabolic risk factors of atherosclerosis.

Registry

clinicaltrials.gov

Start Date

February 2012

End Date

May 2015

Last Updated

10 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Korea University

Responsible Party

Principal Investigator

Kyung Mook Choi

Professor

Korea University

Eligibility Criteria

Inclusion Criteria

•Apparently healthy people who underwent medical routine check up in Korea Health Promotion Center.
•age \> 20 years

Exclusion Criteria

•History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
•Stage 2 hypertension
•Severe renal or hepatic disease

Outcomes

Primary Outcomes

The impact of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) for developing metabolic syndrome in prospective design

Time Frame: 36months

Secondary Outcomes

The relationship of various cardiovascular risk factors (inflammatory markers, hepatokines, adipokines, body composition parameters) with metabolic syndrome and atherosclerosis measured by baPWV and carotid IMT in cross sectional design(36months)